192 related articles for article (PubMed ID: 6372074)
21. Gastric acid secretion and gut hormone release in patients undergoing pancreaticoduodenectomy.
Sato T; Imamura M; Matsuro S; Sasaki I; Ohneda A
Surgery; 1986 Jun; 99(6):728-34. PubMed ID: 3520915
[TBL] [Abstract][Full Text] [Related]
22. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
Ebert R; Frerichs H; Creutzfeldt W
Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
[TBL] [Abstract][Full Text] [Related]
23. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
[TBL] [Abstract][Full Text] [Related]
24. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.
Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE
Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318
[TBL] [Abstract][Full Text] [Related]
25. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
26. Preceding hyperinsulinemia prevents demonstration of insulin effect on fat-induced gastric inhibitory polypeptide (GIP).
Stöckmann F; Ebert R; Creutzfeldt W
Diabetes; 1984 Jun; 33(6):580-5. PubMed ID: 6373462
[TBL] [Abstract][Full Text] [Related]
27. Gastric acid secretion and gastrin and gastric inhibitory polypeptide release in cirrhotic patients.
Sato T; Imamura M; Sasaki I; Ohneda A
Am J Gastroenterol; 1985 Mar; 80(3):163-9. PubMed ID: 3883751
[TBL] [Abstract][Full Text] [Related]
28. Effect of glucose-dependent insulinotropic polypeptide (GIP) on insulin response to glucose in acromegalics.
Pierluissi J; de Pierluissi RM
Acta Cient Venez; 1995; 46(2):89-96. PubMed ID: 9279024
[TBL] [Abstract][Full Text] [Related]
29. The role of endogenous gastric inhibitory polypeptide in the enteroinsular axis.
Takemura J; Seino Y; Yamamura T; Tsuda K; Seino S; Itoh N; Imura H
J Clin Endocrinol Metab; 1982 May; 54(5):909-13. PubMed ID: 7037822
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
Creutzfeldt W; Talaulicar M; Ebert R; Willms B
Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299
[TBL] [Abstract][Full Text] [Related]
31. Gastric inhibitory polypeptide secretion after radical pancreatoduodenectomy.
Miyata M; Nakao K; Tanaka Y; Sakamoto T; Hamaji M; Taketani H; Kawashima Y
Ann Surg; 1984 Mar; 199(3):281-5. PubMed ID: 6367676
[TBL] [Abstract][Full Text] [Related]
32. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
Lauritsen KB; Moody AJ
Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
[TBL] [Abstract][Full Text] [Related]
33. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
McCullough AJ; Miller LJ; Service FJ; Go VL
J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
[TBL] [Abstract][Full Text] [Related]
34. [The effect of selective proximal vagotomy on gastrin, GIP and insulin blood levels in patients with duodenal ulcer].
Börger HW; Schafmayer A; Becker HD
Chir Forum Exp Klin Forsch; 1978; (1978):25-9. PubMed ID: 752595
[TBL] [Abstract][Full Text] [Related]
35. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
36. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.
Lauritsen KB; Moody AJ; Christensen KC; Lindkaer Jensen S
Scand J Gastroenterol; 1980; 15(7):833-40. PubMed ID: 7010526
[TBL] [Abstract][Full Text] [Related]
37. Release of gastric inhibitory polypeptide (GIP) and gastrin after a test meal with a low glucose load in patients after BII resection, proximal duodenopancreatectomy (PDP) and jejunoileal bypass.
Klapdor R
Res Exp Med (Berl); 1982; 181(1):11-8. PubMed ID: 7134635
[TBL] [Abstract][Full Text] [Related]
38. Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat.
Krarup T; Holst JJ; Larsen KL
Am J Physiol; 1985 Aug; 249(2 Pt 1):E195-200. PubMed ID: 4025540
[TBL] [Abstract][Full Text] [Related]
39. Gastric inhibitory polypeptide in acquired pancreatic diabetes: effects of insulin treatment.
Botha JL; Vinik AI; Child PT
J Clin Endocrinol Metab; 1978 Sep; 47(3):543-9. PubMed ID: 400725
[TBL] [Abstract][Full Text] [Related]
40. The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls.
Jorde R; Schulz TB; Burhol PG; Schulz LB
Regul Pept; 1981 Nov; 2(6):391-9. PubMed ID: 7029674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
